GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
Sample GSM2706294 Query DataSets for GSM2706294
Status Public on Oct 18, 2017
Title 20_9h_RG7834
Sample type SRA
Source name HepRG cells
Organisms Homo sapiens; Hepatitis B virus
Characteristics timepoint: 9h
treatment: RG7834
dose: 100 nM
transfection: HBV
Treatment protocol Differentiated HepaRG (dHepaRG) cells in 24 well plates were infected with HBV at an MOI of 20 for 20 h, before the cells were washed 4 times with PBS to remove the HBV inoculum. At day 7 post-infection, cells were treated with either 100nM of RG7834 ("RG7834") or DMSO ("vehicle").
Growth protocol HepaRG cells (Biopredic International, Saint-Gregoire, France) were cultured in Williams E medium (supplemented with 10% HepaRG growth supplement (Biopredic)) and differentiated using 1.8% DMSO for at least 2 weeks before infection. Afterwards differentiated HepaRG were replated in 24 well format and cultured for one more week before infection
Extracted molecule total RNA
Extraction protocol Total RNA extraction was performed using the QIAGEN RNeasy 96 kit with DNase digestion as per the manufacturer’s instructions. All samples used for analysis had an RNA integrity number >8. The quantity and quality of total RNA were assessed by spectrophotometric analysis and by Agilent Tapestation 2200. Total RNA samples were normalized and randomized for further processing.
Sequencing libraries were generated from 150ng total RNA using the Illumina TruSeq Stranded Total RNA sample preparation kit with Ribo Zero Gold as per manufacturer’s instructions, quantified using the Kapa Library Quantification kit (Kapa Biosystems), normalized to 2nM and pooled as per the randomization plan. Pooled libraries were sequenced on a Illumina HiSeq 2500 sequencer for 2 × 50 cycles using the TruSeq PE Cluster Kit and TruSeq SBS Kit sequencing reagents (Illumina). Each lane was spiked with the PhiX Control library (Illumina) at a final concentration of 1 % (v/v) as a sequencing control
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina HiSeq 2000
Description differentiated HepaRG
Data processing Basecalling with CASAVA
Read quality check with FASTQC
Read mapping onto human genome hg19 with bowtie2
Read mapping onto HBV genome AB267090 with bowtie2
Gene quantification with RefSeq mRNA annotations
Genome_build: hg19
Genome_build: AB267090
Supplementary_files_format_and_content: Read counts and normalized read counts (rpkms) per EntrezGene gene and HBV transcript in gct format
Submission date Jul 18, 2017
Last update date May 15, 2019
Contact name Roland Schmucki
Organization name F. Hoffmann - La Roche AG
Street address Grenzacherstrase
City Basel
ZIP/Postal code 4058
Country Switzerland
Platform ID GPL23794
Series (1)
GSE101575 RNA-seq of HBV-infected differentiated HepaRG under RG7834
BioSample SAMN07361260
SRA SRX3014009

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap